146 related articles for article (PubMed ID: 8035308)
21. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
Li JX; Rice KC; France CP
J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
[TBL] [Abstract][Full Text] [Related]
23. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
Kennett GA; Curzon G
Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats.
Kłodzińska A; Chojnacka-Wójcik E
Psychopharmacology (Berl); 1992; 109(4):466-72. PubMed ID: 1365864
[TBL] [Abstract][Full Text] [Related]
25. Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis.
Raghavendra V; Kulkarni SK
Brain Res; 2000 Mar; 860(1-2):112-8. PubMed ID: 10727629
[TBL] [Abstract][Full Text] [Related]
26. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
[TBL] [Abstract][Full Text] [Related]
27. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
[TBL] [Abstract][Full Text] [Related]
28. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
[TBL] [Abstract][Full Text] [Related]
30. [The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine].
Martin P; Lemonnier F
Encephale; 1994; 20(4):427-35. PubMed ID: 7988407
[TBL] [Abstract][Full Text] [Related]
31. Functional study of rat 5-HT2A receptors using antisense oligonucleotides.
Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
J Neurochem; 2003 Jun; 85(5):1087-100. PubMed ID: 12753068
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA
J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253
[TBL] [Abstract][Full Text] [Related]
33. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
Mokler DJ; Commissaris RL; Warner MR; Rech RH
J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
[TBL] [Abstract][Full Text] [Related]
34. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
Vickers SP; Dourish CT; Kennett GA
Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
[TBL] [Abstract][Full Text] [Related]
35. Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity.
Li JX; Rice KC; France CP
Behav Pharmacol; 2007 Jul; 18(4):283-8. PubMed ID: 17551320
[TBL] [Abstract][Full Text] [Related]
36. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats.
Saydoff JA; Rittenhouse PA; van de Kar LD; Brownfield MS
J Pharmacol Exp Ther; 1991 Apr; 257(1):95-9. PubMed ID: 1850481
[TBL] [Abstract][Full Text] [Related]
37. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
[TBL] [Abstract][Full Text] [Related]
39. Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.
Lee MD; Somerville EM; Kennett GA; Dourish CT; Clifton PG
Psychopharmacology (Berl); 2004 Oct; 176(1):39-49. PubMed ID: 15138762
[TBL] [Abstract][Full Text] [Related]
40. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
Shioda K; Nisijima K; Yoshino T; Kato S
Neurosci Lett; 2010 Oct; 482(3):216-9. PubMed ID: 20655983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
